Savara
Price & Volume
Stats
See moreOpen | $3.55 |
Previous Close | $3.52 |
Day Range | $3.49-$3.55 |
52W Range | $1.89-$4.29 |
Market Cap | $608.3M |
Shares Short | 14M |
Financials
See moreRevenue (12 Mos) | $1,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$77.4M |
Diluted EPS | -$0.51 |
News
See moreYahoo Finance • yesterday
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Savara Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action– SVRA
Yahoo Finance • 2 days ago
Savara Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information – SVRA
Yahoo Finance • 3 days ago
SVRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Savara Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Yahoo Finance • 6 days ago
November 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against SVRA
About
CEO | Mr. Matthew Pauls J.D., M.B.A. |
CFO | Mr. David L. Lowrance CPA |
Address | 1717 Langhorne Newtown Road, Langhorne, PA, United States, 19047 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 59 |
